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The Protein Kinase CK2 Facilitates Repair of
Chromosomal DNA Single-Strand Breaks
sion is itself deregulated in most tumors, and expression
of a CK2 promotes cancer in transgenic mouse models
(Kelliher et al., 1996; Litchfield, 2003; Seldin and Leder,
Joanna I. Loizou,1 Sherif F. El-Khamisy,1
Anastasia Zlatanou,1 David J. Moore,5
Douglas W. Chan,2 Jun Qin,2
Stefania Sarno,3,4 Flavio Meggio,3 1995). CK2 is also implicated in the response of mamma-
lian cells to a variety of stresses, including UV, heatLorenzo A. Pinna,3,4 and Keith W. Caldecott1,*
1Genome Damage and Stability Centre shock, inflammation, and damage to the mitotic spindle
(Ahmed et al., 2002; Keller et al., 2001; Miyata et al.,University of Sussex
Science Park Road 1997). Some of the roles of CK2 in stress response ap-
pear to involve promoting the transcriptional activity ofFalmer, Brighton BN1 9RQ
United Kingdom p53 by phosphorylation of Ser 392 (Hupp et al., 1992;
Keller et al., 2001; Keller and Lu, 2002; Meek et al., 1990).2 Baylor College of Medicine
Houston, Texas 77030 In addition, CK2 can inhibit apoptosis by promoting the
antiapoptotic activity of the apoptosis repressor with3 Universita` di Padova
Colombo 3 caspase recruitment domain (ARC) and by inhibiting
caspase-mediated cleavage of key apoptotic regulators35121 Padova
4 Venetian Institute for Molecular Medicine such as Bid (Desagher et al., 2001; Li et al., 2002b).
Despite intensive investigation, however, many of the35129 Padova
Italy molecular mechanisms by which CK2 impacts on cell
fate are unknown.
Here, we have identified an unanticipated role for CK2.
We show that this essential protein kinase maintains theSummary
genetic integrity of mammalian cells by facilitating the
rapid repair of chromosomal DNA single-strand breaks.CK2 was the first protein kinase identified and is re-
quired for the proliferation and survival of mammalian
cells. Here, we have identified an unanticipated role Results
for CK2. We show that this essential protein kinase
phosphorylates the scaffold protein XRCC1 and thereby XRCC1 Is a Phosphoprotein in Eukaryotic Cells
enables the assembly and activity of DNA single- and Is Phosphorylated by CK2 In Vitro
strand break repair protein complexes in vitro and at XRCC1 is required for the rapid repair of chromosomal
sites of chromosomal breakage. Moreover, we show DNA single-strand breaks in mammalian cells, and mu-
that inhibiting XRCC1 phosphorylation by mutation of tation or disruption of this gene results in increased
the CK2 phosphorylation sites or preventing CK2 ac- frequencies of sister chromatid exchange, chromo-
tivity using a highly specific inhibitor ablates the rapid somal aberration, genetic deletion, and embryonic le-
repair of cellular DNA single-strand breaks by XRCC1. thality in mice (reviewed in Caldecott, 2001, and Thomp-
These data identify a direct role for CK2 in the repair son and West, 2000). The electrophoretic mobility of
of chromosomal DNA strand breaks and in maintaining human XRCC1 expressed in insect (Sf XRCC1) or CHO
genetic integrity. cells was retarded when compared to that expressed
in E. coli (Figure 1A). An identical human XRCC1 ORF
was expressed in each cell type, ruling out the possibilityIntroduction
that a difference in amino acid sequence accounted for
the difference in migration. Moreover, treatment of SfCK2 is a ubiquitous protein kinase with more than 300
putative polypeptide substrates and is a heterotetramer XRCC1 with calf intestinal phosphatase resulted in a
polypeptide of similar electrophoretic mobility to that ofcomprised of two catalytic  subunits (, , or )
and two regulatory  subunits (Meggio and Pinna, 2003; XRCC1 purified from E. coli (Figure 1B). In addition, Sf
XRCC1 but not XRCC1 from E. coli was recognizedLitchfield, 2003; Pinna, 2002). Targeted disruption of the
regulatory  subunit results in embryonic lethality in by anti-phosphothreonine and to a lesser extent anti-
phosphoserine antibodies (Figure 1C and data notmice, and disruption of the catalytic  subunit results
in abnormal spermatogenesis (Buchou et al., 2003; Xu shown). Together, these data indicate that XRCC1 is a
phosphoprotein in eukaryotic cells.et al., 1999). CK2 is a pleiotropic enzyme that appears
to promote cell growth and cell survival through an im- Human XRCC1 possesses a cluster of eight primary
consensus sites for the serine/threonine protein kinasepact on a variety of different molecular processes
(Ahmed et al., 2002; Litchfield, 2003; Pinna, 2002). The CK2, located immediately downstream of the central
BRCT I domain (Figure 1D, underlined residues). Theexpression levels of roughly one quarter of cell growth/
cell cycle genes are deregulated by disruption of CK2 presence of this cluster is conserved in XRCC1 from
both Drosophila melanogaster and Arabidopsis thaliana.subunits in S. cerevisiae (Barz et al., 2003). CK2 expres-
Full-length human XRCC1 purified from E. coli was effi-
ciently phosphorylated by CK2 in vitro as were frag-*Correspondence: k.w.caldecott@sussex.ac.uk
ments of human XRCC1 containing the cluster of CK25 Present address: Syngenta CTL, Alderley Park, Cheshire, SK10
4TJ, United Kingdom. sites (Figure 1E). Arabidopsis thaliana XRCC1, which is
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Figure 1. CK2 Phosphorylates XRCC1 In Vitro
(A) Affinity-purified recombinant human
XRCC1-His (0.1 g) from SF21 (“Sf”), E. coli
(“Ec”), or EM9-XH CHO cells (“CHO”) was im-
munoblotted for XRCC1.
(B) Human XRCC1-His purified from E. coli
(0.1 g) or SF21 cells was treated or mock
treated with calf intestinal phosphatase (CIP)
and immunoblotted for XRCC1.
(C) Human XRCC1-His purified from E. coli
(0.2 g) or SF21 cells was immunoblotted for
anti-phosphothreonine.
(D) Alignment of the central region of human
(“Hu”; NM006297), Drosophila melanogaster
(“Dm”; AJ010073), and Arabidopsis thaliana
(“At”; CAC16136) XRCC1. The linker region
is flanked by vertical dotted lines. Identical
residues are boxed in gray, and the primary
CK2 sites are underlined with the target S/T
residues numbered. Atypical and/or hierar-
chical CK2 target S/T residues are arrowed.
Phosphopeptides identified by mass spec-
troscopy of native human XRCC1 (see [G],
below) are in solid boxes, and synthetic pep-
tides employed for in vitro assays (see [F],
below) are in dotted boxes.
(E) Full-length A. thaliana His-XRCC1
(AtXRCC1) (0.1 g) or full-length or truncated
human His-XRCC1 purified from E. coli was
phosphorylated with human CK2 and [-32P]
ATP and fractionated by SDS-PAGE, and
dried Coomassie blue-stained gels were ex-
amined by autoradiography. Polypeptides
are shown schematically. Black boxes and
asterisks denote BRCT domains and CK2
sites, respectively.
(F) In vitro phosphoradiolabeling by CK2 of an
optimal CK2 target peptide and of synthetic
peptides spanning the primary CK2 consen-
sus sites within the XRCC1 linker were quanti-
fied as described (Meggio et al., 1976). The
sequences spanned by the peptides are high-
lighted in dotted boxes in (D), above.
(G) XRCC1 was immunoprecipitated from
HeLa cell extract, and tryptic fragments, pre-
treated or mock treated as indicated with CIP,
were analyzed by mass spectroscopy as de-
scribed (Zhang et al., 1998). The amino acid location of the peptides and their number of phosphoresidues are shown. The observed peptide
masses were within one decimal place of the expected value.
comprised of just the BRCT I domain and the linker ysis of native XRCC1 from HeLa cells confirmed that
this region is phosphorylated in vivo, identifying a phos-region containing the CK2 sites, was similarly phosphor-
ylated. In contrast, the NTD of human XRCC1 was not phopeptide spanning amino acids 503–546 that was a
mixture of tri- and tetraphosphorylated species (Figuresphosphorylated by CK2, and the C-terminal BRCT do-
main was dispensable for phosphorylation. These data 1D and 1G). This suggests that, in addition to the primary
CK2 sites S518 and T523, the “atypical” CK2 sites T519suggest that XRCC1 is a phosphoprotein in eukaryotic
cells and that the linker between the two BRCT domains and S525 within this region are also phosphorylated.
A synthetic peptide spanning residues 482–494 thatis phosphorylated by CK2 in vitro.
To examine which of the primary CK2 sites within the included the primary CK2 site T488 was also phosphory-
lated in vitro, and this region was similarly phosphory-linker domain might be phosphorylated, we compared
the phosphorylation of four synthetic peptides spanning lated in cells. Surprisingly, the tryptic peptide that en-
compassed this region, spanning residues 459–494, wasthese sites (Figure 1D). In addition, XRCC1 was immuno-
precipitated from HeLa cell extracts and tryptic frag- comprised of uni-, bi-, tri-, and tetraphosphorylated spe-
cies. In addition to T488, this peptide contains an “atypi-ments were analyzed by mass spectroscopy. A syn-
thetic peptide spanning residues 514–530 and including cal” CK2 site at S475 and a hierarchical CK2 site at
S485, which becomes a classical CK2 site followingthe CK2 sites S518 and T523 exhibited the highest affin-
ity and phosphorylation rate of those tested, with the phosphorylation at T488. A synthetic peptide spanning
residues 401–427 and including the primary CK2 siteslatter parameter as rapid as an optimal CK2 peptide
substrate (Figures 1D and 1F). Mass spectroscopic anal- S408, S409, S410, and S421 was also phosphorylated
CK2 and Chromosomal DNA Single-Strand Break Repair
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Figure 2. Phosphorylation of XRCC1 by CK2
Stimulates Binding and Activity of PNK
(A) One microgram of each of the indicated
mock-phosphorylated or CK2-phosphory-
lated “-P” proteins was dot blotted onto nitro-
cellulose and incubated with 32P-PNK probe
(top panel) or stained with amido black (mid-
dle panel). A titration of 1, 0.5, 0.25, and 0.125
g of the indicated mock-phosphorylated or
CK2-phosphorylated “-P” human XRCC1
from E. coli (“Ec XRCC1”) or human XRCC1
from insect cells (“Sf XRCC1”) was dot blot-
ted and incubated with 32P-PNK probe (bot-
tom panel).
(B) Three micrograms of each of the indicated
proteins was dot blotted onto nitrocellu-
lose and either stained with amido black,
incubated with CK2-phosphorylated human
XRCC1 probe (35S-XRCC1-P), or incubated
with mock-phosphorylated human XRCC1
probe (35S-XRCC1). An aliquot of the probe
was taken before phosphorylation or mock
phosphorylation, fractionated by SDS-PAGE,
and analyzed by autoradiography (left panel).
(C) (Top panel) Oligonucleotide duplex (20 ng)
(0.8 pmol) was incubated with 1, 2, 4, or 8 ng PNK in the presence of [-32P] ATP and a 5-fold excess (by weight) of mock-phosphorylated or
CK2-phosphorylated recombinant human XRCC1-His (5, 10, 20, or 40 ng, respectively). (Bottom panel) Sf XRCC1 was dephosphorylated with
-phosphatase and then either mock phosphorylated or phosphorytated with CK2. One hundred nanograms of each protein was incubated
with PNK (8 ng), oligonucleotide duplex, and [-32P] ATP and aliquots sampled when indicated. All reaction products above were separated
by denaturing PAGE.
(D) The indicated 32P-labeled oligonucleotide-gapped duplex (asterisk denotes 32P label) was incubated for 1 hr with recombinant human PNK,
DNA polymerase , DNA ligase III, and either recombinant human XRCC1 from insect cells (Sf XRCC1), XRCC1 from E. coli (“Ec XRCC1”),
or XRCC1 from E. coli subsequently preincubated with CK2 (“Ec XRCC1  CK2”). Each of the proteins was present at 80 (lanes 2, 7, and 12),
40 (lanes 3, 8, and 13), 20 (lanes 4, 9, and 14), 10 (lanes 5, 10, and 15), or 5 nM (lanes 6, 11, and 16). Reaction products were separated by
denaturing PAGE. The position of substrate (20 mer) and product (45 mer) are shown. A reaction lacking recombinant proteins is shown in
lane 1 (“-”).
in vitro, though it is not clear whether these sites are control bound similar amounts of 35S-XRCC1, irrespec-
tive of whether or not this probe was phosphorylated.also phosphorylated in vivo. Finally, a synthetic peptide
spanning the primary CK2 site T453 was not phosphory- We have previously shown that XRCC1 purified from
E. coli stimulates PNK activity and SSBR reactions inlated in vitro, and this residue was similarly not phos-
phorylated in vivo (J.Q., unpublished data). In summary, which PNK is limiting (Whitehouse et al., 2001). We there-
fore examined whether PNK activity was higher in thethe C-terminal linker region in XRCC1 is phosphorylated
in vitro and in vivo at a minimum of eight sites, including presence of phosphorylated XRCC1 than mock-phos-
phorylated XRCC1. Indeed, the 5-DNA kinase activityat least three primary CK2 consensus sites and four
atypical or hierarchical CK2 sites. of PNK was greater if XRCC1 was phosphorylated than
if it was not, in reactions in which the DNA kinase activity
was rate limiting (Figure 2C). In addition, the efficiency
XRCC1 Phosphorylation by CK2 Stimulates of SSBR reactions reconstituted with purified proteins
PNK Binding In Vitro was greater in the presence of Sf XRCC1 (or Ec XRCC1
We have reported previously that XRCC1 interacts with preincubated with CK2) than with nonphosphorylated
and stimulates human polynucleotide kinase (White- Ec XRCC1 (Figure 2D). Together, these data suggest
house et al., 2001). To examine whether XRCC1 phos- that phosphorylation of XRCC1 by CK2 stimulates PNK
phorylation by CK2 influences PNK interaction, recombi- binding, activity, and also SSBR reactions in vitro.
nant human XRCC1 purified from E. coli or insect cells
was dot blotted onto nitrocellulose with or without prior
phosphorylation by recombinant CK2 and compared for XRCC1 Phosphorylated by CK2 Interacts
with the FHA Domain of PNKits ability to bind human 32P-PNK probe. Phosphorylation
by CK2 of full-length XRCC1 or XRCC1402–633 purified from Intriguingly, the amino terminus of human PNK pos-
sesses a putative fork head-associated (FHA) domain,E. coli greatly stimulated interaction with PNK in this
assay (Figure 2A). Indeed, phosphorylation of full-length a ubiquitous phosphopeptide binding motif that can me-
diate interactions with phosphorylated proteins (Du-XRCC1 increased binding to PNK probe more than 10-
fold to a level similar to that observed with Sf XRCC1. rocher et al., 1999) (Figure 3A). Consistent with the no-
tion that PNK interacts with phosphorylated XRCC1 viaSimilar results were observed in complementary experi-
ments in which dot-blotted PNK was incubated with this domain, whereas wild-type human PNK interacted
with XRCC1 in the yeast two-hybrid assay, PNKR35A har-mock-phosphorylated or CK2-phosphorylated 35S-XRCC1
probe (Figure 2B). In contrast, DNA ligase III (Lig3) boring a mutated FHA domain did not (Figure 3B). Arg35
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Figure 3. An FHA Domain in PNK and CK2 Sites in XRCC1 Are Required for XRCC1-PNK Interaction
(A) Alignment of the putative FHA domain at the N terminus of PNK with the consensus FHA domain (NCBI; pfam00498). Identical residues
are boxed, and highly conserved residues are underlined. Residues thought to contact phosphothreonine are arrowed.
(B) Yeast Y190 cells harboring the two-hybrid constructs pACT-XRCC1 and either pGBKT7-PNK, pGBKT7-PNKR35A, or empty pGBTK7 were
examined for protein-protein interaction by -galactosidase filter assays (top panel). Cellular levels of human PNK and PNKR35A were examined
by immunoblotting (lower panel).
(C) The indicated proteins (0.5 g) were slot blotted onto nitrocellulose and stained with amido black (first panel) or were CK2-phosphorylated
(second panel, “CK2”) or mock phosphorylated (third panel, “mock”) and then slot blotted and incubated with 35S-PNK1–130 probe. A titration
of 0.5, 0.25, 0.125, and 0.06 g of CK2-phosphorylated “-P” or mock-phosphorylated XRCC1 from E. coli was slot blotted and incubated with
35S-PNK probe (fourth panel). (Fifth panel) Mock-dephosphorylated “X” or -phosphatase-treated “X-” human XRCC1 from insect cells (0.5
g) was fractionated by SDS-PAGE and stained with Coomassie blue “CB” or was slot blotted and stained with amido black “AB” or incubated
with 35S-PNK1–130 probe. An aliquot of the 35S-PNK1–130 probe, fractionated by SDS-PAGE and detected by autoradiography, is shown (right panel).
(D) XRCC1-His was affinity purified from the indicated whole-cell extracts (1.5 mg total protein) and immunoblotted for the indicated proteins.
The mobility of XRCC1 and XRCC1CKM purified from E. coli is also shown (top right).
(E) Human XRCC1 or XRCC1CKM and PNK, Pol, or Lig3 were examined for interaction by yeast two-hybrid analysis using -galactosidase
fliter assays.
(F) (Left) The indicated cell extracts were immunoblotted for XRCC1 and PNK. (Right) Histidine-tagged XRCC1 was affinity purified from cell
extract from the indicated mock-treated or H202-treated CHO cells and recovered proteins immunoblotted for PNK and XRCC1.
corresponds to the structurally and functionally essen- In agreement with these data, an amino-terminal frag-
ment of PNK of 130 amino acids (PNK1–130) that encom-tial Arg70/Arg117 in the Rad53/Chk2 FHA domains, re-
spectively (Durocher et al., 1999, 2000; Li et al., 2002a). passed the 100 amino acid FHA domain was sufficient
for interaction with XRCC1 in vitro (Figure 3C). A radiola-These data indicate that assembly of the XRCC1-PNK
protein complex in vivo requires the cluster of CK2 sites beled 35S-PNK1–130 probe interacted with full-length hu-
man XRCC1 from E. coli if the latter protein was firstin XRCC1 and a putative FHA domain in PNK.
CK2 and Chromosomal DNA Single-Strand Break Repair
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phosphorylated with CK2 but not if XRCC1 was mock act with sites of poly (ADP-ribose) (PAR) synthesis at
DNA strand breaks (Masson et al., 1998; Okano et al.,phosphorylated. Phosphorylation-dependent interac-
tion of 35S-PNK1–130 was also observed with XRCC11–529 2003; Pleschke et al., 2000; El-Khamisy et al., 2003). We
next examined the possibility that the CK2 sites mightand XRCC1402–633, proteins that contain the linker domain,
but not with XRCC11–170, an amino-terminal fragment that influence the recruitment of XRCC1 to sites of PAR,
because the region of XRCC1 that binds this polymerlacks this domain (Figures 1E and 3C). Similar results
were observed when these XRCC1 fragments were ex- is located near these sites. In undamaged EM9-XH cells,
XRCC1 was detected as a diffuse nuclear stain (Figureamined for PNK interaction using yeast two-hybrid anal-
ysis (data not shown). Importantly, pretreatment with 4A, top panels). However, after exposure to H202 fol-
lowed by a 10 min incubation in drug-free media toCK2 was not necessary for interaction of 35S-PNK1–130
with recombinant human Sf XRCC1, and pretreatment of initiate repair, XRCC1 was additionally detected in dis-
crete nuclear foci (Figure 4A, middle panels). Similarthis protein with -phosphatase reduced binding (Figure
3C, bottom panels). 35S-PNK1–130 failed to interact with results were observed following exposure to  rays (Fig-
ure 4A, bottom panels). Anti-XRCC1 signal was absentBSA or casein-negative controls, irrespective of whether
or not these proteins were phosphorylated with CK2. from EM9-V cells transfected with empty vector, both
before and after exposure to H202 or  rays, confirmingTaken together, these data indicate that the 35S-PNK1–130
fragment encoding the FHA domain is sufficient for spe- the specificity of the antibody (Figure 4C). The XRCC1
nuclear foci induced in EM9-XH cells by H202 colocalizedcific interaction with the CK2-phosphorylated linker do-
main of XRCC1. with sites of PAR, confirming that they reflected recruit-
ment of XRCC1 to sites of DNA strand breakage (Figure
4B). The appearance of XRCC1 foci was rapid and tran-Importance of the CK2 Phosphorylation
sient after exposure to H202 (Figure 4D), consistent withSites in XRCC1 In Vivo
the rapidity of SSBR. More importantly, however, XRCC1To examine the importance of the CK2 phosphorylation
nuclear foci failed to appear in EM9-XHCKM cells aftersites in XRCC1 in cells, each of the eight primary target
treatment with H202 (Figures 4A and 4D). These dataserine/threonine residues within the linker was changed
suggest that the conserved CK2 consensus sites areto alanine. XRCC1 mutant EM9 CHO cells were then
required for the assembly of XRCC1 into nuclear foci atstably transfected with empty pcD2E expression vector
DNA strand breaks. PNK was also detected in discreteor with pcD2E encoding either wild-type histidine-tagged
nuclear immunofoci in H2O2-treated EM9-PNK/XH cellshuman XRCC1 or mutant XRCC1CKM (CK2-Mutated). A
after a 10 min incubation in drug-free medium (Figure 5A,comparison of the XRCC1 and XRCC1CKM proteins affin-
“EM9-PNK/XH”), and a number of these foci colocalizedity purified from the transfected cell lines by metal-che-
with XRCC1 (Figure 5B). Strikingly, however, PNK failedlate chromatography revealed that the mobility of the
to appear in nuclear foci in EM9-PNK cells lackingmutated protein was accelerated and was not recog-
XRCC1 or in EM9-PNK/XHCKM cells expressing mutatednized by anti-phosphothreonine antibodies, consistent
XRCC1, during the same time course (Figure 5A, “EM9-with the loss of phosphorylation status (Figure 3D). Note
PNK” and “EM9-PNK/XHCKM”). These data indicate thatthat this was not the case if XRCC1CKM was purified from
the cluster of CK2 phosphorylation sites in XRCC1 isE. coli, the mobility of which was similar to that of wild-
required for the appearance of PNK nuclear foci at sitestype XRCC1 (Figure 3D, top right panel). Mutation of the
of DNA strand breakage after H202. This is consistentCK2 sites reduced or ablated the interaction of XRCC1
with the model in which XRCC1 recruits PNK to chromo-with PNK in cells when measured by the ability of PNK
somal DNA strand breaks (Whitehouse et al., 2001).to copurify with XRCC1 from CHO cell extracts (Figure
3D, third panel) or by yeast two-hybrid analysis (Figure The data described above strongly suggest a novel
3E). Mutation of the CK2 sites had much less effect on role for CK2 in the recruitment/assembly of DNA repair
the interaction of XRCC1 with Pol or Lig3 (Figures 3D protein complexes into nuclear foci after oxidative DNA
and 3E). damage. We wished to confirm this notion by examining
In the experiments described so far, the interaction the assembly of XRCC1 protein complexes in cells that
between XRCC1 and PNK was observed in the absence lack CK2 activity. However, such cells are currently un-
of exogenous DNA damage. We therefore compared the available, primarily because the absence of CK2 activity
level of PNK corecovered with XRCC1-His from CHO is most likely cell lethal (Buchou et al., 2003; Padma-
cells before and after DNA damage. Because the anti- nabha et al., 1990; Xu et al., 1999). To circumvent this
PNK antibodies available to us did not recognize rodent problem, we employed a relatively new and highly spe-
PNK very well in crude extracts, we created cell lines that cific inhibitor of CK2 to transiently reduce or ablate the
expressed human PNK in addition to histidine-tagged activity of this protein kinase. To date, 4,5,6,7-tet-
human XRCC1 (Figure 3F). Approximately 3-fold more rabromo-2-azabenzamidazole (TBB) is the most specific
PNK copurified with XRCC1-His from EM9-PNK/XH cells inhibitor of CK2 available, selectively inhibiting this en-
after H202 treatment than before treatment (Figure 3F). zyme among a panel of 33 other protein kinases tested
Together, these data indicate that the CK2 phosphoryla- so far (Sarno et al., 2001, 2002). The remarkable specific-
tion sites within the XRCC1 linker are important for inter- ity of this inhibitor reflects its ability to fit almost perfectly
action with cellular PNK and suggest that the level of into a hydrophobic pocket within the active site of the
this interaction increases after exposure to H202.  subunits, whereas the size and shape of this pocket
in other protein kinases is less able to bind TBB (Battis-
tutta et al., 2001). More importantly, it has been demon-CK2 Facilitates Recruitment of XRCC1 and PNK
to Chromosomal DNA Strand Breaks strated that CK2 can be rendered relatively resistant to
TBB by a single mutation (V66A) within this pocketXRCC1 appears to be recruited to sites of DNA strand
breakage in mammalian cells through an ability to inter- (Sarno et al., 2001, 2002). This is because valine 66 is
Cell
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Figure 4. CK2 Phosphorylation Sites in
XRCC1 Are Required for Recruitment of
XRCC1 into Nuclear Foci at Sites of DNA
Strand Breakage
(A) The indicated cells were mock treated,
treated with H202 (10 mM for 10 min), or ex-
posed to  rays (4 Gy) and then incubated for
10 min in drug-free medium. Fixed cells were
immunostained with anti-XRCC1 Mab and
counterstained with DAPI.
(B) EM9-XH cells were mock treated or
treated with H202 as above, fixed, and immu-
nostained with a mixture of anti-XRCC1 poly-
clonal antibody and anti-PAR Mab.
(C) EM9-V cells were treated as in (A) above
and immunostained with anti-XRCC1 Mab.
(D) EM9-XH (black bars) and EM9-XHCKM cells
were treated with H202 as described above,
and the fraction of cells with more than five
XRCC1 nuclear foci was determined before
H202 treatment (“-”), immediately after drug
treatment (“0”), and after the indicated repair
periods in drug-free medium. Note that
XRCC1 foci were not detected in EM9-XHCKM
cells at any time point.
an alanine in other protein kinases and is a major reason mammalian cells (Ruzzene et al., 2002; Sarno et al., 2001)
prevented the assembly of XRCC1 nuclear foci followingthat the hydrophobic pocket of CK2 is so distinctive
(Battistutta et al., 2001). We therefore created stable treatment with H202, supporting a role for CK2 in this
process (Figure 5C, left panels). Preincubation with TBBEM9-XH transfectants that express small amounts of
either wild-type human CK2 or the TBB-resistant vari- also prevented the assembly of H202-induced XRCC1
foci in EM9-XH/CK2 cells expressing wild-type recom-ant CK2V66A. The total level of CK2 polypeptide was
identical in pooled populations of the two transfected binant CK2 (Figure 5C, middle panels). In contrast,
however, TBB failed to prevent the assembly of H202-cell lines and was not measurably different from that
level present in nontransfected EM9 cells (data not induced XRCC1 foci in EM9-XH/CK2V66A cells express-
ing TBB-resistant CK2 (Figure 5C, right panels). TBBshown). Preincubation of EM9-XH cells with a concen-
tration of TBB (75 M) known to inhibit CK2 activity in did not have any measurable impact in any of the cell
CK2 and Chromosomal DNA Single-Strand Break Repair
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Figure 5. CK2 Facilitates Recruitment of Both XRCC1 and PNK into Nuclear Foci at Sites of Chromosomal DNA Strand Breakage
(A) The indicated cell lines were mock treated or H202 treated (10 mM for 10 min) and then incubated in drug-free medium for 10 min. Fixed
cells were immunostained with anti-PNK Mab and counterstained with DAPI.
(B) EM9-PNK/XH cells were treated with H202 as described above and immunostained with a mixture of anti-XRCC1 Mab and anti-PNK polyclonal.
(C) The indicated cell lines were mock treated or H202 treated as described above and immunostained with anti-XRCC1 Mab. Where indicated,
cells were incubated throughout the experiment with the CK2 inhibitor TBB (75 M), including preincubation with inhibitor for 60 min prior to
H202 treatment.
lines in the absence of H202 (data not shown). These by the comet assay, is comprised of at least two XRCC1-
dependent pathways, including a rapid pathway thatresults confirm that CK2 facilitates the recruitment or
assembly of XRCC1 into nuclear foci after oxidative operates throughout interphase and a second pathway
that is S/G2 phase specific and which may operate spe-DNA damage.
cifically at the replication fork (Moore et al., 2000; Taylor
et al., 2000, 2002). In addition, there is a slower XRCC1-CK2 Facilitates the Rapid Repair of Chromosomal
DNA Single-Strand Breaks independent pathway that appears to operate through-
out interphase (Taylor et al., 2002; Thompson et al.,We next examined the importance of the CK2 sites for
the repair of chromosomal SSBs. SSBR, as measured 1982).
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ress into and through S phase (Moore et al., 2000). Con-
sistent with this notion, EM9-XHCKM cells were only
slightly if at all more sensitive to H202 treatment or  rays
than were EM9-XH cells (Figure 6B). We have shown
previously that, whereas the rapid SSBR process is criti-
cal for maintaining genetic integrity in noncycling cells,
S/G2-specific SSBR is the major determinant of cell
survival in cycling cells (Moore et al., 2000; Taylor et al.,
2000, 2002).
The data described above demonstrate that the CK2
phosphorylation sites in XRCC1 are required for the
rapid repair of chromosomal SSBs after H202 or  rays. To
confirm that CK2 facilitates this process, we compared
SSBR in EM9-XH and EM9-V cells in the presence and
absence of TBB. These data are presented as tail mo-
ment distributions in order to detect any variation within
cell populations in the response to TBB. Whereas EM9-
XH cells repaired most H202-induced SSBs within 1 hr
in the absence of TBB, SSBR was substantially retarded
in EM9-XH cells in the presence of TBB (Figure 7, “EM9-
XH” panels). It was noted that the rate of SSBR in EM9-
XH cells in the presence of TBB was similar to the resid-
ual rate of repair that remains in EM9-V cells, consistentFigure 6. CK2 Sites in XRCC1 Are Required for the Rapid Repair of
with the notion that TBB greatly inhibits or ablatesChromosomal Single-Strand Breaks
XRCC1-dependent SSBR (Figure 7, compare “EM9-XH”(A) The indicated cells were mock treated or treated with 150 M
H202 for 10 min (top left) or with  rays (20 Gy) (bottom left) and DNA filled bars and “EM9-V” open bars). Indeed, this was
strand breakage measured by the alkaline comet assay. The cells confirmed by the observation that TBB had little or no
were also mock treated or treated with 150 M H202 for 10 min (top effect on the rate of SSBR in EM9-V cells lacking XRCC1
right) or with  rays (20 Gy) (bottom right) and incubated for the (Figure 7, “EM9-V,” compare open and closed bars).
indicated repair times in drug-free medium. In each experiment,
This observation is important because it indicates thatthe average tail moments for 100 cells/sample was calculated, and
TBB only inhibits SSBR conducted by XRCC1, stronglythe data are the mean of three independent experiments ( 1 SD).
suggesting that the role of CK2 in SSBR is confined to(B) The indicated cell lines were plated into 6-well dishes (250 cells/
well) and treated for 10 min at 37	C with H202 or  rays and surviving the XRCC1-mediated repair.
colonies counted after 10–14 days. Data are the mean of three To confirm that CK2 facilitates SSBR in mammalian
independent experiments ( 1 SD). cells, we employed EM9-XH/CK2 and EM9-XH/
CK2V66A cells expressing small amounts of wild-type or
TBB-resistant human CK2. EM9-XH/CK2 and EM9-
Treatment of EM9 cells with H202 for 10 min resulted XH/CK2V66A cells were treated with H202 for 10 min andin a dose-dependent increase in SSBs, as measured by
then incubated in drug-free medium for up to 45 min to
the comet tail moment (data not shown). The comet tail allow time for repair. Untreated EM9-XH/CK2 and EM9-
moment is the product of the tail length and the fraction XH/CK2V66A cells exhibited mean tail moments of 
2
of DNA in the tail and is a reliable measure of DNA single- prior to treatment with H202 and mean tail moments ofstranded damage. For subsequent experiments, an H202 20 after treatment, indicating that both cell lines ac-
dose (150 M) was chosen that was on the linear region crued similar levels of damage (data not shown). In the
of the dose-response curve. Exposure to H202 for 10 min absence of TBB, EM9-XH/CK2 cells repaired many of
resulted in a similar tail moment in each cell line (Figure their H202-induced SSBs during the first 15 min in drug-
6A, top left panel). However, the tail moment values free medium and most of their SSBs within 45 min, with
dropped at much slower rates in EM9 and EM9-XHCKM 90% of cells exhibiting tail moments of five or less at
cells than in EM9-XH cells during a subsequent 2 hr the latter time point (Figure 7, “EM9-XH/CK2,” open
incubation in drug-free medium, indicating that XRCC1CKM bars). However, as observed in EM9-XH cells, TBB se-
was unable to support the rapid repair of SSBs after verely inhibited SSBR in EM9-XH/CK2 cells during the
H202 (Figure 6A, top right panel). Similar results were 45 min repair period (“EM9-XH/CK2,” compare open
observed when EM9-XH, EM9-XHCKM, or EM9-V cells and filled bars). Consequently, less than 20% of cells
were exposed to  rays, with the latter two cell lines exhibited a tail moment of five or less at the end of
repairing SSBs more slowly than EM9-XH cells (Figure the repair period. In striking contrast, EM9-XH/CK2V66A
6A, lower panels). cells repaired SSBs almost as fast in the presence of
It was noted that the H202-induced SSBs that remained TBB as in the absence of TBB, with70% of cells exhib-
unrepaired after 2 hr in EM9-XHCKM cells were fully re- iting tail moments of five or less after a 45 min repair
paired after 24 hr. This indicates that the SSBR defect period (“EM9-XH/CK2V66A” open and filled bars). Thus,
imposed by mutation of the CK2 sites was restricted to the expression of TBB-resistant CK2 circumvents the
the rapid repair process. This, in turn, suggests that the impact of this inhibitor on chromosomal SSBR. These
CK2 sites are not required for XRCC1 function during data demonstrate that CK2 facilitates the repair of chro-
the S/G2-specific repair process which, over a longer mosomal single-strand breaks in mammalian cells after
oxidative DNA damage.time period, can remove unrepaired SSBs as cells prog-
CK2 and Chromosomal DNA Single-Strand Break Repair
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Figure 7. CK2 Facilitates the Repair of Chromosomal DNA Single-Strand Breaks
The indicated cell lines were mock treated or H202 treated (150 M for 10 min) and then incubated in drug-free medium for the indicated repair
period. The distribution of tail moments among a population of 100 cells for each time point was plotted. Where indicated, the CK2 inhibitor
TBB (75 M) was present throughout the experiment, including preincubation for 0–60 min prior to H202 treatment. Results are the mean
(EM9-XH and EM9-V) or representative (EM9-XH/CK2 and EM9-XH/CK2V66A) distributions of three independent experiments per cell line,
with the same result observed in each experiment.
Discussion unclear whether or not there is any interaction between
nonphosphorylated XRCC1 and PNK. We have reported
previously that human XRCC1 from E. coli stimulatesPhosphorylation of XRCC1 by CK2 Stimulates
Binding and Activity of PNK PNK activity in vitro (Whitehouse et al., 2001). This may
reflect a level of phosphorylation-independent interac-XRCC1 is required for the rapid repair of chromosomal
DNA single-strand breaks in mammalian cells and for tion between XRCC1 and PNK or, alternatively, that
XRCC1 stimulates PNK through another mechanism,embryonic viability in mice (Caldecott, 2001; Thompson
and West, 2000). Consequently, CHO cells in which such as an impact of binding by XRCC1 to DNA on the
structure or accessibility of SSBs (Marintchev et al.,XRCC1 is mutated exhibit increased frequencies of sis-
ter chromatid exchange, chromosomal aberration, and 1999). We have observed some signal with nonphos-
phorylated XRCC1 in dot blots incubated with labeledgenetic deletion. At the molecular level, XRCC1 interacts
with multiple components of DNA single-strand break PNK probe, particularly high-activity 32P-PNK probe
(e.g., see Figure 2A, second lane). However, it is difficultrepair machinery, including poly (ADP-ribose) polymer-
ase (Caldecott et al., 1996; Masson et al., 1998), AP to exclude the possibility that this level of signal reflects
nonspecific background. Conversely, while we have soendonuclease (Vidal et al., 2001), DNA polynucleotide
kinase (Whitehouse et al., 2001), DNA polymerase- far failed to detect interaction between XRCC1CKM and
PNK in CHO or yeast cells, we cannot rule out the pres-(Caldecott et al., 1996; Kubota et al., 1996), and DNA
ligase III (Caldecott et al., 1994). XRCC1 appears to ence of residual interaction between these proteins.
Nevertheless, irrespective of whether or not nonphos-act as a molecular scaffold, recruiting and/or stimulating
the enzymatic components of the repair process at phorylated XRCC1 can interact with PNK to some ex-
tent, it is clear that phosphorylation of XRCC1 by CK2each stage.
The results described in the current study suggest greatly promotes this interaction.
Most if not all of the cellular complement of XRCC1that XRCC1 interacts with PNK via an FHA domain in
the latter protein and that this interaction is regulated appears to be phosphorylated, even in cells that have
not been exposed to genotoxin. This may reflect phos-by phosphorylation of XRCC1 by CK2. However, it is
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phorylation occurring in response to endogenous levels of lesions that are difficult to repair or perhaps SSBR
factories. It thus seems likely that CK2 phosphorylationof DNA damage or, perhaps more likely, that XRCC1 is
constitutively phosphorylated. Despite this, gel filtration impacts on XRCC1 function in one or more as yet un-
identified ways.and quantitative immunoblotting experiments suggest
that relatively little (5%–15%) of the cellular comple- Although a role for CK2 in DNA repair has not pre-
viously been reported, it has been reported that CK2 isment of XRCC1 and PNK are bound together in un-
treated cells (unpublished data and Whitehouse et al., involved in the transcriptional response to DNA damage.
In S. cerevisiae, CK2 is a component of the TFIIIB com-2001). After exposure to H202, we observed an increase
in the steady-state level of XRCC1-PNK complex. Al- plex, in which it keeps TBP in a phosphorylated state
and maintains pol III transcriptional activity (Ghavidelthough this increase is small (3-fold), this may reflect
that SSBR reactions are very rapid, and it is consistent and Schultz, 2001). CK2 subunits appear to be expelled
from the complex in response to DNA damage, resultingwith the model that PNK associates very transiently with
XRCC1 in response to DNA damage (Whitehouse et al., in downregulation of pol III activity. In addition, CK2 is a
component of the mammalian chromatin transcriptional2001). It remains to be determined how the interaction
between XRCC1 and PNK is regulated after DNA dam- elongation factor FACT, within which it appears to pref-
erentially phosphorylate p53 in response to UV (Kellerage, though we have observed an apparent increase in
phosphorylation at the cluster of CK2 sites after H202 et al., 2001). Here, we have identified an unanticipated
role of this intriguing protein kinase in the cellular re-(unpublished data). In addition, TBB ablated SSBR me-
diated by XRCC1 in cells that had as little as up to sponse to DNA damage—maintaining genetic integrity
through DNA repair.1 hr preincubation with inhibitor, suggesting that CK2
activity is required during and immediately after strand
Experimental Proceduresbreakage. This is consistent with a requirement for addi-
tional phosphorylation of XRCC1 by CK2 during SSBR.
Proteins, Cell Lines, and Expression ConstructsIn this regard, the observation from mass spectroscopic
Recombinant human histidine-tagged XRCC1 and PNK proteins
analysis that there are multiple species of phosphory- were expressed and purified essentially as described (Whitehouse
lated XRCC1 in untreated cells may be relevant. One et al., 2001; Caldecott et al., 1996; Taylor et al., 2002). pcD2E and
pcD2EXH encoding C-terminally histidine-tagged XRCC1 have beenpossibility is that some or all of the eight primary CK2
described previously (Caldecott et al., 1994; Kadkhodayan et al.,sites in XRCC1 are constitutively phosphorylated and
1996). pcD2E-CK2 and pcD2E-CK2V66A were generated by amplifi-are sufficient to support a small amount of XRCC1-PNK
cation of CK2 from an ORF present in the bacterial expressioncomplex in untreated cells but that further phosphoryla-
construct pT7-7 and subcloning into pcD2E.
tion by CK2 after DNA damage (perhaps at secondary CHO cells were maintained in -MEM (GIBCO) containing 10%
or hierarchical sites within the linker) increases the affin- fetal calf serum. Expression constructs were introduced into EM9
cells by calcium phosphate coprecipitation and selected with G418ity of PNK FHA domain for XRCC1.
(1.5 mg/ml). In the case of EM9-PNK/XH, EM9-PNK/XHCKM, EM9-
XH/CK2, and EM9-XH/CK2V66A cells, EM9 cells were transfectedCK2 Facilitates Chromosomal Single-Strand
with pcD2E-PNK, pcD2ECK2, or pcD2ECK2V66A and selected in
Break Repair G418, then a single clone of EM9-PNK cells, or a pooled population
Mutation of the cluster of eight primary CK2 sites in of EM9-CK2 or EM9-CK2V66A cells, was transfected with pcD2EXH
or pcD2EXHCKM and selected for the presence of XRCC1 orXRCC1 severely inhibited the rapid repair of chromo-
XRCC1CKM in medium containing CldUrd (Thompson et al., 1990).somal SSBs. Moreover, the highly specific CK2 inhibitor
TBB similarly inhibited rapid SSBR, and expression of
Dot Blot Assays and Phosphorylation by CK2 In Vitroa TBB-resistant isoform of CK2 restored this process.
Recombinant proteins (1 g) were spotted or slot blotted ontoThese data demonstrate that CK2 facilitates the rapid
Hybond-C nitrocellulose. Dot blots employing 32P-PNK or 35S-XRCC1
repair of chromosomal SSBs in mammalian cells. Impor- probes were incubated in HBB (25 mM Tris-HCl [pH 7.5], 25 mM
tantly, the mechanism by which CK2 promotes the repair NaCl, 5 mM MgCl2, 1 mM DTT) for 60 min at 4	C and then blocked
in HYB100 (20 mM Tris-HCl [pH 7.5], 100 mM KCl, 2.5 mM MgCl2,of SSBs is restricted to SSBR mediated by XRCC1, be-
0.1 mM EDTA, 1 mM DTT, 0.05% Nonidet P-40, 1 mM DTT) pluscause in the absence of XRCC1, TBB had little or no
1% or 5% nonfat dried milk (NFDM) for 30 min at 4	C. Probeseffect on the residual rate of SSBR. It is likely that the
were employed in HYB100  1% NFDM overnight at 4	C and filtersimpact of CK2 on the interaction of XRCC1 with PNK is
analyzed by autoradiography. Slot blots employing 35S-PNK probe
a major component of the role of CK2 during SSBR, were blocked in 25 mM HEPES (pH 7.5), 100 mM NaCl, 1 mM DTT,
presumably by both stimulating PNK activity and aiding 1% NFDM for 30 min at 4	C; rinsed; and incubated in the above
lacking NFDM but containing probe for 3 hr at 4	C. 32P-radiolabeledrecruitment of this enzyme to chromosome breaks. Nev-
recombinant human PNK probe (1 g in 50 l) was prepared withertheless, this is unlikely to be the only role played by
50Ci [-32P] ATP (4500 Ci/mmol;ICN), 1 mU unit human CK2 (RocheCK2 during SSBR. For example, mutation of the CK2
Molecular Biochemicals) in HBB for 30 min at 25	C. Unincorporatedphosphorylation sites in XRCC1 or specific inhibition of
[-32P] ATP was removed using a Nuc-trap column (Stratagene) and
CK2 activity disrupted the appearance of XRCC1 nu- the probe employed at 50 ng/ml. 35S-XRCC1 or 35S-PNK probes
clear foci after DNA damage, suggesting that CK2 is were prepared in E. coli as described (Caldecott et al., 1994), purified
by metal chelate affinity or anion exchange chromatography, andrequired for the assembly of XRCC1 protein complexes
employed at 1 g/ml (35S-XRCC1 probe) or 10–30 g/ml (35S-PNKat chromosomal DNA strand breaks. The precise nature
probes). 35S-XRCC1 probes were phosphorylated where indicatedof these foci is unclear. However, that they represent
with CK2 in the presence of 1 mM ATP and 10 mM MgCl2. Forsites of strand breakage is supported by their colocaliza-
mapping CK2 sites, 0.1 g recombinant XRCC1 protein was incu-
tion with sites of PAR synthesis. There appear to be too bated for 30 min at 25	C with human CK2 or rat liver CK2 (F.M. and
few XRCC1 foci to represent sites of single nicks or L.A.P.) in HBB and either 1 mM ATP or 0.1 mM ATP plus 4 Ci
[-32P]-ATP (4500 Ci/mm [ICN]).gaps, but these structures could represent a subset
CK2 and Chromosomal DNA Single-Strand Break Repair
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Indirect Immunofluorescence nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res.
31, 5526–5533.Subconfluent cell monolayers on coverslips were treated as de-
scribed in the text and fixed with 3% paraformaldehyde/2% sucrose Ghavidel, A., and Schultz, M.C. (2001). TATA binding protein-associ-
or (for anti-PAR) methanol-acetone (1:1, vol/vol) and then permeabil- ated CK2 transduces DNA damage signals to the RNA polymerase
ized. Primary antibodies were anti-XRCC1 Mab (33-2-5), anti-PNK III transcriptional machinery. Cell 106, 575–584.
Mab (kindly provided by Michael Weinfeld), anti-poly (ADP-ribose)
Hupp, T.R., Meek, D.W., Midgley, C.A., and Lane, D.P. (1992). Regu-
Mab (10H; a gift from Glibert de Murcia), and anti-XRCC1 polyclonal
lation of the specific DNA binding function of p53. Cell 71, 875–886.
(AHP428, Serotec). Secondary antibodies were goat FITC anti-
Kadkhodayan, S., Salazar, E.P., Lamerdin, J.E., and Weber, C.A.mouse Fab (DAKO), Cy3-goat anti-rabbit IgG (Sigma), FITC-anti-
(1996). Construction of a functional cDNA clone of the hamsterrabbit IgG (DAKO), and TRITC-anti-mouse IgG (Sigma). Nuclei were
ERCC2 DNA repair and transcription gene. Somat. Cell Mol. Genet.counterstained with 0.000025% DAPI. Analysis was with a Zeiss
22, 453–460.Axioplan-2 fluorescence microscope with photographs at 100
Keller, D.M., and Lu, H. (2002). p53 serine 392 phosphorylation in-magnification.
creases after UV through induction of the assembly of the
CK2.hSPT16.SSRP1 complex. J. Biol. Chem. 277, 50206–50213.DNA Strand Break Repair Assays
Strand-strand break repair reactions in vitro and using alkaline Keller, D.M., Zeng, X., Wang, Y., Zhang, Q.H., Kapoor, M., Shu, H.,
comet assays were conducted as described previously (Whitehouse Goodman, R., Lozano, G., Zhao, Y., and Lu, H. (2001). A DNA dam-
et al., 2001; Moore et al., 2000; Taylor et al., 2000). age-induced p53 serine 392 kinase complex contains CK2, hSpt16,
and SSRP1. Mol. Cell 7, 283–292.
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